Our Services
Medical Information
Helpful Resources
Published on: 7/21/2026
Wegovy (semaglutide) can cause low blood sugar (hypoglycemia) symptoms such as dizziness, shakiness, sweating, and confusion. This happens because Wegovy slows stomach emptying, increases insulin release after meals, and reduces appetite—raising risk when meals are skipped, exercise increases, or other glucose-lowering medications are used.
Key prevention strategies include:
Symptoms like dizziness on Wegovy can have multiple causes, from dehydration to medication interactions to underlying conditions. Because self-diagnosis can delay proper care, the smartest next step is to clarify what your symptoms may mean. Take a free, instant, online symptom check to better understand your situation and confidently plan your next steps.
Reviewed for medical accuracy: 07/21/2026
Wegovy (semaglutide) is a once-weekly prescription medication approved for chronic weight management. It works by mimicking a hormone called GLP-1 that helps regulate appetite and blood sugar. Many people tolerate it well, but some report feeling dizzy, shaky, or weak—symptoms often associated with low blood sugar (hypoglycemia). This guide explains why it happens, how to spot warning signs, and practical steps to prevent blood sugar crashes while on Wegovy.
Keywords: Wegovy and blood sugar crashes
Even though semaglutide alone rarely causes dangerous drops, these factors can combine to produce dizziness, shakiness, sweating, or confusion.
Early detection is key. Common hypoglycemia symptoms include:
If you ignore these signs, you might progress to more serious symptoms: blurred vision, slurred speech, weakness, or in extreme cases, loss of consciousness.
If you're experiencing these symptoms and want to better understand whether they could be related to Hypoglycemia, a free AI-powered symptom checker can help you assess your condition in just a few minutes.
Monitor Regularly
Plan Balanced Meals
Don't Skip Meals or Snacks
Adjust Medication with Professional Guidance
Stay Hydrated
Moderate Intense Exercise
Limit Alcohol Intake
Note: If you become unconscious or can't swallow safely, seek emergency help immediately.
Always involve your healthcare team in managing medication and diet changes. Contact them if you experience:
If you're starting or increasing your Wegovy dose and notice dizziness or shakiness, schedule an appointment to review your treatment plan.
If you ever feel that your symptoms are serious or potentially life threatening, please speak to a doctor or seek emergency care right away. Your safety comes first.
(References)
* Davies, M., Færch, K., Jeppesen, O. K., Kvist, K., & Pedersen, S. D. (2024). Semaglutide 2.4 mg and the Risk of Hypoglycemia in Patients With Obesity Without Diabetes: A Pooled Analysis of the STEP Clinical Trials. *Diabetes, Obesity and Metabolism*, *26*(4), 1438-1447. pubmed.ncbi.nlm.nih.gov/38318788/
* Shah, M., Patel, S., & Singh, R. (2021). Hypoglycemia with GLP-1 receptor agonists in non-diabetic individuals: A systematic review. *Journal of Clinical and Translational Endocrinology*, *25*, 100257. pubmed.ncbi.nlm.nih.gov/34320215/
* Wharton, S., Batterham, R. L., Clemmensen, K. K., & Christensen, E. L. (2022). Semaglutide 2.4 mg for weight management: A narrative review of clinical trials. *Diabetes, Obesity and Metabolism*, *24*(11), 2145-2158. pubmed.ncbi.nlm.nih.gov/36365445/
* Kalra, S., Sahay, R., & Mehta, A. (2023). Hypoglycemia in Non-Diabetic Individuals: What Do We Know and What Do We Need to Know? *Journal of the Endocrine Society*, *7*(10), bcad105. pubmed.ncbi.nlm.nih.gov/37688005/
* Ray, E. C., Fleser, B. K., Miller, A., Ray, L. M., & Rusk, J. S. (2024). Dietary strategies to manage side effects of glucagon-like peptide-1 receptor agonists. *Nutrition in Clinical Practice*, *39*(2), 273-281. pubmed.ncbi.nlm.nih.gov/38209214/
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.